Home › Cancer (all types) › Illinois › Charleston
Cancer (all types) clinical trials in Charleston, IL
4 studies for Cancer (all types) are looking for participants at sites in and around Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RecruitingPhase 3
- Carle Physician Group-Mattoon/Charleston, Mattoon · 11 mi away
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Recruiting
- Carle Physician Group-Mattoon/Charleston, Mattoon · 11 mi away
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- Carle Physician Group-Mattoon/Charleston, Mattoon · 11 mi away
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
- Carle Physician Group-Mattoon/Charleston, Mattoon · 11 mi away
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX122 studies
- New York City, NY110 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Washington, DC60 studies
- Philadelphia, PA60 studies
- Durham, NC59 studies
- Chicago, IL52 studies
- Seattle, WA50 studies
- Atlanta, GA50 studies
- Arlington, VA48 studies
Other studies in Charleston
- Non-Small Cell Lung Cancer8 studies
- Lung Cancer8 studies
- Prostate Cancer7 studies
- Breast Cancer5 studies
- Colorectal Cancer5 studies
- Head and Neck Squamous Cell Carcinoma5 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Melanoma4 studies
- Hypopharyngeal Cancer4 studies
- Bladder Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.